Mangoceuticals (MGRX) Equity Ratio (2023 - 2025)
Mangoceuticals' Equity Ratio history spans 3 years, with the latest figure at 0.95 for Q3 2025.
- For Q3 2025, Equity Ratio rose 1.77% year-over-year to 0.95; the TTM value through Sep 2025 reached 0.95, up 1.77%, while the annual FY2024 figure was 0.91, 23.06% up from the prior year.
- Equity Ratio for Q3 2025 was 0.95 at Mangoceuticals, up from 0.92 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.95 in Q3 2025 and bottomed at 3.18 in Q1 2024.
- The 3-year median for Equity Ratio is 0.91 (2023), against an average of 0.53.
- The largest annual shift saw Equity Ratio crashed 442.61% in 2024 before it skyrocketed 129.28% in 2025.
- A 3-year view of Equity Ratio shows it stood at 0.74 in 2023, then rose by 23.06% to 0.91 in 2024, then increased by 4.86% to 0.95 in 2025.
- Per Business Quant, the three most recent readings for MGRX's Equity Ratio are 0.95 (Q3 2025), 0.92 (Q2 2025), and 0.93 (Q1 2025).